Vanguard Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q4 | – | Sell |
-891,025
| Closed | -$66.8M | – | 4274 |
|
2015
Q3 | $66.8M | Buy |
891,025
+175,549
| +25% | +$13.2M | ﹤0.01% | 1709 |
|
2015
Q2 | $53.9M | Buy |
715,476
+103,098
| +17% | +$7.76M | ﹤0.01% | 1897 |
|
2015
Q1 | $30.7M | Buy |
612,378
+128,219
| +26% | +$6.43M | ﹤0.01% | 2149 |
|
2014
Q4 | $16.8M | Buy |
484,159
+14,746
| +3% | +$511K | ﹤0.01% | 2308 |
|
2014
Q3 | $15.4M | Buy |
469,413
+54,261
| +13% | +$1.78M | ﹤0.01% | 2301 |
|
2014
Q2 | $15.9M | Buy |
415,152
+13,651
| +3% | +$524K | ﹤0.01% | 2301 |
|
2014
Q1 | $16M | Buy |
401,501
+69,806
| +21% | +$2.78M | ﹤0.01% | 2273 |
|
2013
Q4 | $12.4M | Buy |
331,695
+137,984
| +71% | +$5.14M | ﹤0.01% | 2364 |
|
2013
Q3 | $8.85M | Buy |
193,711
+36,836
| +23% | +$1.68M | ﹤0.01% | 2453 |
|
2013
Q2 | $4.24M | Buy |
+156,875
| New | +$4.24M | ﹤0.01% | 2756 |
|